Skip to main content
. 2021 Dec 20;19(1):352–365. doi: 10.1007/s13311-021-01149-9

Table 1.

Means and standard deviations for outcome variables of the modified intent-to-treat sample

Variable Food-specific neurofeedback (n = 19) General neurofeedback (n = 19)
Baseline Δ Pretreatment Δ Posttreatment Δ 3 months Baseline Δ Pretreatment Δ Posttreatment Δ 3 months
Clinical measures
Objective binge-eating episodes 4.32 (3.64)  −0.26 (2.56)  −2.96 (3.90)  −2.33 (4.66) 4.32 (2.77)  −0.32 (3.73)  −2.05 (3.06)  −2.61 (4.58)
Eating disorder psychopathology 3.06 (1.03)  −0.13 (0.59)  −0.35 (0.78)  −0.45 (0.97) 2.83 (1.08)  − 0.08 (0.58)  −0.14 (0.75)  −0.55 (0.83)
Food craving 58.89 (11.15)  −1.58 (10.88)  −11.11 (14.22)  −10.90 (20.44) 62.21 (12.01)  −4.00 (8.29)  −12.93 (10.41)  −19.05 (13.87)
Self-efficacya 28.32 (4.73)  −0.05 (3.85)  −0.12 (3.18) 0.52 (3.03) 24.74 (4.94) 0.21 (3.08) 1.24 (2.43) 2.02 (3.18)
Perceived stress 42.19 (18.22) 3.86 (16.85) 4.73 (14.85) 2.11 (15.09) 52.19 (19.37)  −1.23 (13.65)  −1.81 (18.51)  −2.42 (21.83)
Depressive symptoms 7.42 (3.27) 0.68 (2.50) 0.04 (3.42) 0.16 (3.33) 9.11 (4.15) 0.58 (4.91)  −0.65 (4.93) 0.14 (6.05)
Impact of weight on quality of life 108.26 (14.76) 3.79 (8.89) 6.25 (11.27) 5.52 (12.89) 108.35 (12.77) 0.06 (7.53) 2.40 (13.72) 7.20 (13.56)
Subjective impulsivity 30.02 (6.73) 0.40 (3.22) 1.24 (4.44) 1.41 (4.90) 35.45 (5.70) 1.44 (4.56) 1.56 (5.93) 1.18 (5.11)
Body mass index 36.65 (5.71) 0.01 (0.65)  −0.04 (2.72)  −1.08 (3.18) 35.60 (4.40)  −0.99 (2.97)  −0.02 (1.41)  −0.56 (1.80)
Waist-to-hip ratio 0.86 (0.08) 0.02 (0.04) 0.02 (0.06) 0.02 (0.06) 0.90 (0.09) 0.00 (0.04) 0.00 (0.06)  −0.01 (0.05)
Executive functions
Decision makinga  −4.21 (36.05)  −4.95 (27.84) 3.35 (37.48) 18.92 (34.31) 4.95 (35.58) 17.26 (41.14) 25.44 (31.56) 27.38 (42.30)
Cognitive flexibilitya 0.02 (4.09)  −1.92 (4.75) 0.95 (4.33) 2.39 (5.17) 2.17 (8.74)  −2.82 (8.70)  −1.18 (8.39)  −1.81 (8.89)
Impulsivitya 0.45 (0.28) 0.05 (0.14) 0.14 (0.16) 0.14 (0.21) 0.57 (0.26) 0.08 (0.15) 0.07 (0.20) 0.10 (0.18)
Planninga 15.63 (3.69) 1.37 (3.40) 1.01 (2.85) 1.03 (3.66) 17.63 (2.99)  −0.21 (3.33) 0.82 (3.25)  −0.16 (3.11)
Inhibitory control 10.05 (7.79)  −1.69 (6.40)  −2.57 (7.15)  −1.28 (8.44) 10.32 (5.00)  −2.65 (3.49)  −2.69 (4.91)  −2.45 (4.15)
Alertness 1.82 (1.07) 0.03 (1.32)  −0.37 (1.09)  −0.19 (1.24) 2.17 (1.31)  −0.50 (1.64)  −0.06 (2.07)  −0.39 (1.62)

N = 38. Δ, Difference score of pre-, posttreatment, 3-month follow-up minus baseline. Objective binge-eating episodes: Eating Disorder Examination; eating disorder psychopathology: Eating Disorder Examination-Questionnaire (0–6* less favorable scores are asterisked); food craving: Food Cravings Questionnaire-trait-reduced (15–90*); self-efficacy: General Self-Efficacy Scale (10*–49); perceived stress: Perceived Stress Questionnaire (0–100*); depressive symptoms: Patient Health Questionnaire-Depression (0–27*); impact of weight on quality of life: Impact of Weight on Quality of Life-Lite (31–155*); subjective impulsivity: Barratt Impulsiveness Scale (15–60*); decision making: Iowa Gambling Task; cognitive flexibility: Wisconsin Card Sorting Test; impulsivity: Delay Discounting Task, planning: Tower of London; inhibitory control: visual Go/NoGo paradigm

aPositive difference values represent effects in expected direction